Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome

Evangelia G Kranias1, Roger J Hajjar

  • 1Department of Pharmacology and Cell Biophysics, College of Medicine, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH 45267-0575, USA. Litsa.Kranias@uc.edu

Insights

Heart failure impairs cardiac contractility by affecting calcium handling. New research reveals complex regulation of the SERCA2 pump by phospholamban and other proteins, offering novel therapeutic targets.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Heart disease is a leading cause of death, with heart failure characterized by impaired contractile function.
  • Current therapies address symptoms, not underlying subcellular mechanisms of heart failure.
  • Impaired calcium sequestration into the sarcoplasmic reticulum (SR) is a hallmark of failing hearts.

Purpose of the Study:

  • To review the regulatory mechanisms of cardiac contractility involving the SERCA/PLN complex.
  • To explore new therapeutic strategies targeting this complex for heart failure treatment.

Main Methods:

  • Literature review of studies on cardiac calcium handling and SERCA2 regulation.
  • Analysis of the roles of phospholamban (PLN) and newly identified regulatory proteins.
  • Discussion of potential small molecule and gene transfer therapies.

Main Results:

  • The SERCA2 pump's activity is regulated by phospholamban (PLN), with phosphorylation relieving inhibition.
  • New regulators of SERCA activity include SUMO, S100, and histidine-rich Ca-binding protein.
  • PLN activity is further modulated by inhibitor-1 of protein phosphatase 1 and small heat shock protein 20.

Conclusions:

  • Cardiac contractility is regulated by a multimeric SERCA/PLN ensemble.
  • Understanding these complex regulatory mechanisms opens avenues for novel heart failure therapeutics.
  • Targeting the SERCA/PLN complex with small molecules or gene transfer shows therapeutic potential.

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Smooth Muscle Contraction01:25

Smooth Muscle Contraction

Smooth muscle contraction is a complex process vital for various bodily functions, from maintaining blood vessel tension to facilitating the movement of food through the digestive tract. Unlike striated muscles, smooth muscle contraction begins more slowly and lasts longer.
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...